Chunyan Xing
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Retraction Note: Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
Journal: Molecular and cellular biochemistry
Published: September 01, 2023
Clinical Characteristics and Economic Burden of Asthma in China: A Multicenter Retrospective Study.
Journal: Iranian journal of allergy, asthma, and immunology
Published: June 24, 2022
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 09, 2021
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Journal: Molecular cancer
Published: September 18, 2021
Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.
Journal: Molecular and cellular biochemistry
Published: September 08, 2015
Characterizing the epidemiology, virology, and clinical features of influenza in China's first severe acute respiratory infection sentinel surveillance system, February 2011-October 2013.
Journal: BMC infectious diseases
Published: December 02, 2014
Viral aetiology in adults with acute upper respiratory tract infection in Jinan, Northern China.
Journal: Clinical & developmental immunology
Published: January 15, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026